Paulson Richard A. 4
4 · Karyopharm Therapeutics Inc. · Filed Dec 5, 2024
Insider Transaction Report
Form 4
Paulson Richard A.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-12-04$0.81/sh−3,620$2,932→ 1,128,312 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.